Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such ...

A benchtop bioreactor system developed at Hannover Medical School can produce up to 40 million human immune cells per week ...

Scientists routinely press eukaryotic cells into service as organic factories, cranking out everything from antibodies to viruses. How much biomass these researchers need to conduct their research, ...

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

Researchers at Hannover Medical School have published a protocol for producing up to 40 million human macrophages per week from induced pluripotent stem cells using a benchtop bioreactor system. The ...

MHH researchers are developing bioreactors to produce millions of human immune cells. The method opens up new opportunities for research and treatment. Researchers at Hannover Medical School (MHH) ...

A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.

Before the advent of biologics, commercialization of a therapeutic relied on successfully scaling up to meet market demand. This scaling-up strategy expanded biomanufacturing capacity by upsizing the ...